Table 5.
Nanospecific Characteristics | Test Method |
---|---|
Size/size distribution | DLS |
Physical form/shape/morphology | TEM, cryo-TEM |
Surface charge | Zeta potential, electrophoretic mobility (EPM) |
Aggregation behaviour | DLS |
Stability and uniformity | DLS, UV–VIS spectroscopy |
Density/weight/volume fraction of nanomaterial dispersed in the medium | Ultracentrifugation, densitometry |
Drug encapsulation | UV–VIS spectrometry, high-performance liquid chromatography (HPLC) |
Presence of targeting moieties | Kinetic turbidity assays, Spectroscopic assays (UV–VIS, circular dichroism), surface plasmon resonance (SPR) binding assays |
Toxicity | Cytotoxicity assessment using MTT and LDH assays |
Biocompatibility | Immunological response, hemolytic properties |
Structural and functional properties | TEM, SEM, small-angle X-ray scattering (SAXS), NTA, high-resolution transmission electron microscopy (HRTEM), atomic force microscopy (AFM), extended X-ray absorption fine structure (EXAFS), ferromagnetic resonance (FMR), DSC, differential centrifugal sedimentation (DCS), inductively coupled plasma atomic emission spectroscopy (ICP-MS), UV–VIS, matrix-assisted laser desorption/ionization (MALDI), nuclear magnetic resonance (NMR), superparamagnetic relaxometry, tunable resistive pulse sensing (TRPS) |